COMMUNIQUÉS West-GlobeNewswire

Nexstim enters depression therapy market in Sweden

10/05/2019 - 13:00

Press release, Helsinki, 10 May at 2.00 pm (EET) Nexstim enters depression therapy market in Sweden Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated [...]

BioCryst to Present at Bank of America Merrill Lynch Health Care Conference

10/05/2019 - 13:00

RESEARCH TRIANGLE PARK, N.C., May 10, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the Bank of America Merrill Lynch Health Care Conference in [...]

Nabriva Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights

10/05/2019 - 13:00

DUBLIN, Ireland, May 10, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, today [...]

Trevena Reports First Quarter 2019 Results

10/05/2019 - 13:00

— Company announces receipt of FDA feedback on healthy volunteer study protocol and analysis plan for oliceridine — – Study on track to initiate by end of June – Company to host conference call Monday, May 13, 2019 at 8 [...]

Amicus Therapeutics to Present at the Bank of America Merrill Lynch 2019 Health Care Conference

10/05/2019 - 13:00

CRANBURY, N.J., May 10, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will participate in a fireside chat at the Bank of America [...]

ContraFect Reports First Quarter 2019 Financial Results and Provides Business Update

10/05/2019 - 13:00

YONKERS, N.Y., May 10, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents, comprised of lysins and [...]

Recro Pharma Reports First Quarter 2019 Financial Results

10/05/2019 - 13:00

Company to Host Conference Call Today at 8:00 AM ET MALVERN, Philadelphia, May 10, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a pharma company with a high-performing, revenue generating contract [...]

TG Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results

10/05/2019 - 13:00

Conference Call to be held today, Friday, May 10, 2019 at 8:00 AM ET NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the first quarter ended [...]

FDA Approves Prior Approval Supplement for BIVIGAM®

10/05/2019 - 12:58

ADMA Announces it will Commence Commercial Sales of BIVIGAM® RAMSEY, N.J. and BOCA RATON, Fla., May 10, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated [...]

PLx Pharma Inc. Reports First Quarter 2019 Results

10/05/2019 - 12:50

Company submits briefing package to U.S. Food and Drug Administration HOUSTON, May 10, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company [...]

Stemline Therapeutics Reports First Quarter 2019 Financial Results

10/05/2019 - 12:30

Net revenue for ELZONRIS was $5.05 million for the first quarter Conference call and live webcast scheduled for today at 8:00 AM ET NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), [...]

Zomedica Announces Private Placement of Preferred Shares

10/05/2019 - 12:00

ANN ARBOR, Mich., May 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today announced that it [...]

Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019

10/05/2019 - 12:00

RANCHO CUCAMONGA, Calif., May 10, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President and Bill Peters, CFO, will be presenting at the Bank of America [...]

Adynxx Announces Payment Date of Special Cash Dividend Previously Announced by Alliqua BioMedical

10/05/2019 - 12:00

Adynxx announces May 29, 2019 as payment date of previously announced special cash dividend of $1.05 per share to former Alliqua shareholders Adynxx confirms intent to consummate the previously announced distribution of [...]

ASLAN Pharmaceuticals’ Varlitinib Selected by Leading Korean Gastric Cancer Group for Study in Second-Line Gastric Cancer

10/05/2019 - 10:15

- K-MASTER, Korea’s leading precision medicine research group, to conduct phase 1b/2 umbrella study testing varlitinib as a second-line treatment in HER1/HER2 co-expressing advanced or metastatic gastric cancer patients [...]

Virbac : Declaration of the number of shares and voting rights April 2019

10/05/2019 - 09:43

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]

Virbac : Déclaration d'actions et droits de vote Avril 2019

10/05/2019 - 09:43

DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]

Ambu A/S: Ambu appoints new CEO

10/05/2019 - 08:10

Ambu’s board of directors has appointed Juan-José Gonzalez as the new CEO, effective May 15, 2019, to replace Lars Marcher who resigns from his position. Jens Bager, Chairman of the Ambu Board of Directors, comments, “ [...]

GENFIT: Ordinary Shareholder’s Meeting of June 13, 2019 – Availability of Preparatory Documents

10/05/2019 - 08:05

GENFIT: Ordinary Shareholder’s Meeting of June 13, 2019 – Availability of Preparatory Documents Lille (France), Cambridge (Massachusetts, United States), May 10, 2019 – GENFIT (Nasdaq and Euronext: GNFT) , a late-stage [...]